Karin Botha
Finanzdirektor/CFO bei GUARD THERAPEUTICS INTERNATIONAL AB
Ursprung des Netzwerks ersten Grades von Karin Botha
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 11 | |
Matting AB
 Matting AB Home FurnishingsConsumer Durables Matting AB supplies carpets for shops, offices, public environments, and industry. It offers entrance mats, workplace mats, and tactile joints and rugs for dog sports arenas. The firm also provides lightning. The company was founded in 1970 and is headquartered in Alingsas, Sweden.
1
| Subsidiary | Home Furnishings | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Karin Botha
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NOBINA AB (PUBL) | Other Transportation | Chairman Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Graduate Degree | |
| SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
| COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
| DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| OT Pharmaceuticals AB | Chief Executive Officer | ||
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
| Synartro AB | Chairman | ||
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| ELECTROLUX AB | Electronics/Appliances | Corporate Officer/Principal | |
| Kabigen AB | Investor Relations Contact | ||
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| University of Adelaide | College/University | Investor Relations Contact | |
| Actinova AB | Director/Board Member | ||
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Active Security Trading AB | Director/Board Member | ||
| CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Investor Relations Contact | |
| Actionaid AB | Chairman | ||
| Gideon & Partners AB | Director/Board Member | ||
ActionAid International Sweden
 ActionAid International Sweden Miscellaneous Commercial ServicesCommercial Services ActionAid International Sweden operates as a membership organization. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AB Consiliario | Director/Board Member | ||
| Metynex Pharmaceuticals AB | Director/Board Member | ||
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
| Antaros Holding AB | Director/Board Member | ||
| Antaros Renostic AB | Chairman | ||
Antaros Medical AB
 Antaros Medical AB Miscellaneous Commercial ServicesCommercial Services Antaros Medical AB provides scientific, technical, research and development services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Johannes Hulthe. Johannes Hulthe has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree | |
Core Ventures LLC
 Core Ventures LLC Investment ManagersFinance Core Ventures LLC is an Independent Venture Capital firm founded in 2009. Core Ventures LLC is headquartered in Short Hills. | Investment Managers | Chief Investment Officer | |
| University of Stockholm | College/University | Graduate Degree | |
| Gårdarike Fastigheter AB | Director/Board Member | ||
| Gårdarike Invest AB | Director/Board Member | ||
OnTarget Chemistry AB
 OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
Gårdarike AB
 Gårdarike AB Real Estate DevelopmentFinance Gårdarike AB manages real estate properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Naventus Corporate Finance AB
 Naventus Corporate Finance AB Investment Banks/BrokersFinance Naventus Corporate Finance AB is an investment boutique and transaction manager that provides dedicated and experienced corporate finance services. The private company is based in Stockholm, Sweden and was founded in 2017 by Lars Höckenström. Naventus has a team with extensive experience and knowledge, which helps them understand their clients' needs and build a long-term strategy to strengthen value creation. The Swedish company has a broad sector- and transaction expertise that enables them to provide their clients with a strong track-record. | Investment Banks/Brokers | Founder |
Statistik
International
| Schweden | 45 |
| Vereinigte Staaten | 4 |
| Island | 2 |
| Australien | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 15 |
| Finance | 10 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Transportation | 2 |
Operativ
| Director/Board Member | 70 |
| Independent Dir/Board Member | 20 |
| Corporate Officer/Principal | 16 |
| Chairman | 16 |
| Chief Executive Officer | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Karin Botha
- Unternehmensverbindungen
